Seoul, South Korea

Kyung Mi Cho

This inventor holds 1 USPTO granted patent. Top assignee: Samyang Corporation. Active years: 2010.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Kyung Mi Cho in Nanoparticle Drug Delivery

Introduction

Kyung Mi Cho is an accomplished inventor based in Seoul, South Korea. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on nanoparticle compositions for oral administration.

Latest Patents

Kyung Mi Cho holds a patent for "Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof." This invention relates to an orally administrable composition containing nanoparticles with a particle size of 500 nm or less. The composition includes 0.1-30 weight % of a complex of a water-soluble drug and a counter-ion substance, 0.5-80 weight % of a lipid, 0.5-80 weight % of a polymer, and 1-80 weight % of an emulsifier. The invention boasts a high gastrointestinal absorption rate upon oral administration, a high drug entrapping rate in the nanoparticle, and stability against lipases.

Career Highlights

Kyung Mi Cho is currently employed at Samyang Corporation, where she continues to advance her research in drug delivery technologies. Her work has garnered attention for its potential to improve the efficacy of oral medications.

Collaborations

Kyung Mi Cho collaborates with notable colleagues, including Mi Hong Min and Jun Seok Hwang, to further enhance the development of innovative drug delivery systems.

Conclusion

Kyung Mi Cho's contributions to nanoparticle drug delivery represent a significant advancement in the field of pharmaceuticals. Her innovative approach has the potential to transform how water-soluble drugs are administered orally, leading to improved patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…